{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:47:20Z","timestamp":1788850040050,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10072-021-05811-0","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:03:46Z","timestamp":1642637026000},"page":"3939-3947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-1678","authenticated-orcid":false,"given":"Giuseppe","family":"Liberatore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Giannotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiore","family":"Manganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Cocito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Briani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Maurizio","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolama Alessandra","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Cavaletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Carpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Emiliano","family":"Doneddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cotti Piccinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdita","family":"Peci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Querol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Nobile-Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"issue":"3-4","key":"5811_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000494291","volume":"52","author":"MC Broers","year":"2019","unstructured":"Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC (2019) Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology. 52(3-4):161\u2013172. https:\/\/doi.org\/10.1159\/000494291","journal-title":"Neuroepidemiology."},{"issue":"9","key":"5811_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","volume":"86","author":"EK Mathey","year":"2015","unstructured":"Mathey EK, Park SB, Hughes RAC et al (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 86(9):973\u2013985. https:\/\/doi.org\/10.1136\/jnnp-2014-309697","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5811_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/WCO.0000000000000595","volume":"31","author":"PE Doneddu","year":"2018","unstructured":"Doneddu PE, Nobile-Orazio E (2018) Management of chronic inflammatory demyelinating polyradiculopathy. Curr Opin Neurol 31(5):511\u2013516. https:\/\/doi.org\/10.1097\/WCO.0000000000000595","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"5811_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/jnnp-2018-318714","volume":"90","author":"PE Doneddu","year":"2019","unstructured":"Doneddu PE, Cocito D, Manganelli F et al (2019) Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database. J Neurol Neurosurg Psychiatry 90(2):125\u2013132. https:\/\/doi.org\/10.1136\/jnnp-2018-318714","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5811_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-018-0027-2","volume":"4","author":"BC Kieseier","year":"2018","unstructured":"Kieseier BC, Mathey EK, Sommer C, Hartung H-P (2018) Immune-mediated neuropathies. Nat Rev Dis Primer 4(1):31. https:\/\/doi.org\/10.1038\/s41572-018-0027-2","journal-title":"Nat Rev Dis Primer"},{"issue":"23","key":"5811_CR6","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JKM Ng","year":"2012","unstructured":"Ng JKM, Malotka J, Kawakami N et al (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 79(23):2241\u20132248. https:\/\/doi.org\/10.1212\/WNL.0b013e31827689ad","journal-title":"Neurology."},{"issue":"10","key":"5811_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology. 82(10):879\u2013886. https:\/\/doi.org\/10.1212\/WNL.0000000000000205","journal-title":"Neurology."},{"issue":"10","key":"5811_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","volume":"2","author":"H Ogata","year":"2015","unstructured":"Ogata H, Yamasaki R, Hiwatashi A et al (2015) Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2(10):960\u2013971. https:\/\/doi.org\/10.1002\/acn3.248","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"5811_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"JJ Devaux","year":"2016","unstructured":"Devaux JJ, Miura Y, Fukami Y et al (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology. 86(9):800\u2013807. https:\/\/doi.org\/10.1212\/WNL.0000000000002418","journal-title":"Neurology."},{"issue":"1","key":"5811_CR10","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1212\/NXI.0000000000000639","volume":"7","author":"A Cortese","year":"2020","unstructured":"Cortese A, Lombardi R, Briani C et al (2020) Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype. Neurol - Neuroimmunol Neuroinflamm 7(1):e639. https:\/\/doi.org\/10.1212\/NXI.0000000000000639","journal-title":"Neurol - Neuroimmunol Neuroinflamm"},{"key":"5811_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","volume":"301","author":"M Kadoya","year":"2016","unstructured":"Kadoya M, Kaida K, Koike H et al (2016) IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol 301:16\u201322. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.013","journal-title":"J Neuroimmunol"},{"key":"5811_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jneuroim.2017.05.002","volume":"309","author":"EK Mathey","year":"2017","unstructured":"Mathey EK, Garg N, Park SB et al (2017) Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies. J Neuroimmunol 309:41\u201346. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.002","journal-title":"J Neuroimmunol"},{"issue":"7","key":"5811_CR13","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/brain\/awx124","volume":"140","author":"E Delmont","year":"2017","unstructured":"Delmont E, Manso C, Querol L et al (2017) Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain. 140(7):1851\u20131858. https:\/\/doi.org\/10.1093\/brain\/awx124","journal-title":"Brain."},{"issue":"1","key":"5811_CR14","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","volume":"90","author":"E Burnor","year":"2018","unstructured":"Burnor E, Yang L, Zhou H et al (2018) Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology. 90(1):e31\u2013e38. https:\/\/doi.org\/10.1212\/WNL.0000000000004773","journal-title":"Neurology."},{"issue":"3","key":"5811_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.23794","volume":"73","author":"L Querol","year":"2013","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2013) Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy: contactin-1 in Aggressive CIDP. Ann Neurol 73(3):370\u2013380. https:\/\/doi.org\/10.1002\/ana.23794","journal-title":"Ann Neurol"},{"issue":"6","key":"5811_CR16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura Y, Devaux JJ, Fukami Y et al (2015) Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 138(6):1484\u20131491. https:\/\/doi.org\/10.1093\/brain\/awv054","journal-title":"Brain."},{"issue":"7","key":"5811_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","volume":"86","author":"K Doppler","year":"2015","unstructured":"Doppler K, Appeltshauser L, Wilhelmi K et al (2015) Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry 86(7):720\u2013728. https:\/\/doi.org\/10.1136\/jnnp-2014-309916","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"5811_CR18","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler K, Appeltshauser L, Villmann C et al (2016) Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain. 139(10):2617\u20132630. https:\/\/doi.org\/10.1093\/brain\/aww189","journal-title":"Brain."},{"issue":"6","key":"5811_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1515\/cclm-2017-0792","volume":"56","author":"J Klehmet","year":"2018","unstructured":"Klehmet J, M\u00e4rschenz S, Ruprecht K et al (2018) Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP). Clin Chem Lab Med CCLM 56(6):919\u2013926. https:\/\/doi.org\/10.1515\/cclm-2017-0792","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"6","key":"5811_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/mus.26051","volume":"57","author":"JM Martinez-Thompson","year":"2018","unstructured":"Martinez-Thompson JM, Snyder MR, Ettore M et al (2018) Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM. Muscle Nerve 57(6):1000\u20131005. https:\/\/doi.org\/10.1002\/mus.26051","journal-title":"Muscle Nerve"},{"issue":"1","key":"5811_CR21","doi-asserted-by":"publisher","first-page":"14411","DOI":"10.1038\/s41598-017-14853-4","volume":"7","author":"L Querol","year":"2017","unstructured":"Querol L, Siles AM, Alba-Rovira R et al (2017) Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy. Sci Rep 7(1):14411. https:\/\/doi.org\/10.1038\/s41598-017-14853-4","journal-title":"Sci Rep"},{"key":"5811_CR22","doi-asserted-by":"publisher","unstructured":"Liberatore G, Manganelli F, Doneddu PE et al (2020) Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? Eur J Neurol. Published online October 15, ene.14545. https:\/\/doi.org\/10.1111\/ene.14545","DOI":"10.1111\/ene.14545"},{"issue":"1","key":"5811_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision. J Peripher Nerv Syst 15(1):1\u20139. https:\/\/doi.org\/10.1111\/j.1529-8027.2010.00245.x","journal-title":"J Peripher Nerv Syst"},{"key":"5811_CR24","doi-asserted-by":"publisher","first-page":"577288","DOI":"10.1016\/j.jneuroim.2020.577288","volume":"345","author":"G Liberatore","year":"2020","unstructured":"Liberatore G, Giannotta C, Sajeev BP et al (2020) Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. J Neuroimmunol 345:577288. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577288","journal-title":"J Neuroimmunol"},{"issue":"11","key":"5811_CR25","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/01.wnl.0000344569.13496.ff","volume":"72","author":"E Nobile-Orazio","year":"2009","unstructured":"Nobile-Orazio E, Terenghi F, Giannotta C, Gallia F, Nozza A (2009) Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology. 72(11):1024\u20131026. https:\/\/doi.org\/10.1212\/01.wnl.0000344569.13496.ff","journal-title":"Neurology."},{"issue":"1-2","key":"5811_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jns.2007.09.020","volume":"266","author":"E Nobile-Orazio","year":"2008","unstructured":"Nobile-Orazio E, Gallia F, Terenghi F, Allaria S, Giannotta C, Carpo M (2008) How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J Neurol Sci 266(1-2):156\u2013163. https:\/\/doi.org\/10.1016\/j.jns.2007.09.020","journal-title":"J Neurol Sci"},{"key":"5811_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"RAC Hughes","year":"2001","unstructured":"Hughes RAC, Bensa S, Willison HJ et al (2001) Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:195\u2013201. https:\/\/doi.org\/10.1002\/ana.1088","journal-title":"Ann Neurol"},{"issue":"2","key":"5811_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mus.26488","volume":"60","author":"A Breiner","year":"2019","unstructured":"Breiner A, Bourque PR, Allen JA (2019) Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosis. Muscle Nerve 60(2):180\u2013183. https:\/\/doi.org\/10.1002\/mus.26488","journal-title":"Muscle Nerve"},{"key":"5811_CR29","doi-asserted-by":"publisher","first-page":"577074","DOI":"10.1016\/j.jneuroim.2019.577074","volume":"337","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zheng P, Devaux JJ et al (2019) Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China. J Neuroimmunol 337:577074. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577074","journal-title":"J Neuroimmunol"},{"issue":"12","key":"5811_CR30","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","volume":"267","author":"E Delmont","year":"2020","unstructured":"Delmont E, Brodovitch A, Kouton L et al (2020) Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera. J Neurol 267(12):3664\u20133672. https:\/\/doi.org\/10.1007\/s00415-020-10041-z","journal-title":"J Neurol"},{"issue":"4","key":"5811_CR31","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1212\/NXI.0000000000000238","volume":"3","author":"A Cortese","year":"2016","unstructured":"Cortese A, Devaux JJ, Zardini E et al (2016) Neurofascin-155 as a putative antigen in combined central and peripheral demyelination. Neurol Neuroimmunol Neuroinflamma 3(4):e238. https:\/\/doi.org\/10.1212\/NXI.0000000000000238","journal-title":"Neurol Neuroimmunol Neuroinflamma"},{"issue":"5","key":"5811_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/jnnp-2012-303440","volume":"84","author":"M Kuwahara","year":"2013","unstructured":"Kuwahara M, Suzuki H, Samukawa M, Hamada Y, Takada K, Kusunoki S (2013) Clinical features of CIDP with LM1-associated antibodies. J Neurol Neurosurg Psychiatry 84(5):573\u2013575. https:\/\/doi.org\/10.1136\/jnnp-2012-303440","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5811_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jns5.12053","volume":"19","author":"E Nobile-Orazio","year":"2014","unstructured":"Nobile-Orazio E (2014) Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst 19(1):2\u201313. https:\/\/doi.org\/10.1111\/jns5.12053","journal-title":"J Peripher Nerv Syst"}],"updated-by":[{"DOI":"10.1007\/s10072-023-07184-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000}}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05811-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T01:04:20Z","timestamp":1701047060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5811"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05811-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10072-023-07184-y","asserted-by":"object"}]},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"15 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10072-023-07184-y","URL":"https:\/\/doi.org\/10.1007\/s10072-023-07184-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of each participating center. All patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. Eduardo Nobile-Orazio reported personal fees for advisory or scientific board from Kedrion, Italy; Baxter, Italy; Novartis, Switzerland; CSL Behring, Italy; LFB, France; and Astellas, the Netherlands, outside the submitted work and travel grants to attend scientific meeting from Baxter, Grifols, Kedrion, and Novartis, Italy. Dr. Pietro Emiliano Doneddu reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Giuseppe Liberatore reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Dario Cocito reported honoraria for lecturing from Shire, CSL Behring, and Kedrion and travel grants to attend scientific meeting from Shire, Kedrion, and CSL Behring. Dr. Erdita Peci reported travel grants to attend scientific meetings from CSL Behring. Dr. Raffaella Fazio has served on scientific advisory boards for CSL Behring and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Dr. Marinella Carpo reported travel grants to attend scientific meetings from Kedrion. Dr. Chiara Briani has served on scientific advisory boards for Pfizer and has received travel grants from Kedrion and CSL Behring to attend scientific meeting. Dr. Giuseppe Cosentino reported travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Andrea Cortese reported travel grants to attend scientific meetings from Kedrion. Dr. Fiore Manganelli reported personal fees for scientific events from CSL Behring and has received travel grants to attend scientific meetings from CSL Behring and Kedrion. Dr. Guido Cavaletti reported honoraria for lecturing and travel grants to attend scientific meetings from Kedrion. Dr. Massimiliano Filosto has served on scientific advisory boards for CSL Behring and Sarepta Therapeutics and has received travel grants from Sanofi-Genzyme, Kedrion, Baxter, and CSL Behring to attend scientific meeting. Dr. Girolama Alessandra Marfia reported consultancy fees and travel fundings from CSL Behring, Kedrion, Shire, and Grifols. Dr. Giovanni Antonini reported honoraria for lecturing from Kedrion and Sanofi-Genzyme, and travel grants from Kedrion, Sanofi-Genzyme, and LJ Pharma. All the other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}